我国农村产业融合发展研究

[目的]农村产业融合发展是打造新农业农村经济增长极的重要载体,是构建蓝绿交织、清新明亮、产业共融的田园综合体的有效途径,对于促进农民增收、农业增效、农村增绿具有重要意义。[方法]文章根据统计数据,通过定性分析的方法,对我国农村产业融合发展意义、现状、机遇及制约因素进行了深入研究。[结果]当前我国农村产业融合发展初见成效,发展模式日益多样化、经营主体逐步多元化、利益联结机制不断健全。新形势下,我国农村产业融合发展的制度环境更加优越、物质基础更加雄厚、市场空间更加广阔、内生动力更加强劲。但是,我国农村产业融合还处于起步阶段,农村产业融合层次浅、新型农业经营主体带动能力弱、利益联结机制松散、要素瓶颈制约尚未打破、基础设施建设滞后等问题比较突出。[结论]提出应从加强顶层设计、完善产业融合模式、强化新型农业经营主体的带动能力、健全利益联结机制、激发多种要素、加强基础设施建设等方面搭建农村产业融合发展平台,促进农村产业融合发展驶入"时代高铁"。     

Converging scientific fields and new technological paradigms as main drivers of the division of scientific labour in drug discovery process: the effects on strategic management of the R&D corporate change

The thesis of this study is that the convergence of genetics, genomics and proteomics spurs new technological paradigms in medicine, which are generating a R&D corporate change: division of scientific labour of the drug discovery process by strategic alliances among firms in order to reinforce the integrative capabilities in different biomedical research fields and collective and cumulative learning between in-house R&D and external sources of innovation. This study shows, by key a case study of pharmaceutical companies, as scientific and technological paradigms in medicine are main drivers of industrial and R&D corporate change to enhance and accelerate the discovery process of ground-breaking drugs for more and more personalised healthcare.     

Cournot games with biconcave demand

Biconcavity is a simple condition on inverse demand that corresponds to the ordinary concept of concavity after simultaneous parameterized transformations of price and quantity. The notion is employed here in the framework of the homogeneous-good Cournot model with potentially heterogeneous firms. The analysis leads to unified conditions, respectively, for the existence of a pure-strategy equilibrium via nonincreasing best-response selections, for existence via quasiconcavity, and for the uniqueness of the equilibrium. The usefulness of the generalizations is illustrated in cases where inverse demand is either “nearly linear” or isoelastic. It is also shown that commonly made assumptions regarding large outputs are often redundant.     

Are rules and boundaries sufficient to limit harmful central bank discretion? Lessons from Europe

Marvin Goodfriend׳s (2014) insightful, informative and provocative work explains concisely and convincingly why the Fed needs rules and boundaries. This paper reviews the broader institutional design problem regarding the effectiveness of the central bank in practice and confirms the need for rules and boundaries. The framework proposed for improving the Fed incorporates key elements that have already been adopted in the European Union. The case of ELA provision by the ECB and the Central Bank of Cyprus to Marfin-Laiki Bank during the crisis, however, suggests that the existence of rules and boundaries may not be enough to limit harmful discretion. During a crisis, novel interpretations of the legal authority of the central bank may be introduced to create a grey area that might be exploited to justify harmful discretionary decisions even in the presence of rules and boundaries. This raises the question how to ensure that rules and boundaries are respected in practice.     

粮食主产区水稻适度规模经营意愿影响因素研究——基于江西省7县428个水稻种植户的调查

[目的]农业适度规模经营是提高我国农业经营主体收入的最佳途径,是粮食主产区现代农业发展、维护国家粮食安全的现实选择。明晰粮食主产区农户水稻适度规模经营意愿水平,并深入考察其影响因素,对进一步提高水稻适度规模经营意愿、扩大土地经营规模具有重要的现实意义。[方法]基于江西省7县428个水稻种植户的实地调查数据,运用Logistic回归模型,借鉴柯布—道格拉斯生产函数,对粮食主产区水稻适度规模经营意愿影响因素进行了实证分析。[结果](1)各县水稻适度规模经营意愿及其影响因素特征存在着一定差异,且它们之间具有较为密切的关系;(2)劳动力、土地、资金和其他因素对粮食主产区水稻适度规模经营意愿均具有显著影响,其中土地因素对水稻适度规模经营意愿影响最为显著,劳动力和资金因素具有较大影响,其他因素影响较小;(3)在引入模型的13个影响因素中,土地规模、土地流转和户主文化程度对水稻适度规模经营意愿影响最为显著,劳动力人数、融资难易程度和非农收入比例次之,户主年龄、人均收入和区域经济水平也有影响,而家庭生命周期、粮食补贴、农业技术培训和购买农业保险则没有对规模经营意愿产生显著影响。[结论]根据以上研究结果,从加快土地流转、提升农户素质、破解融资瓶颈和分区分类推进适度规模经营4个方面提出了相关对策,认为要加快土地流转,扩大土地经营规模,创造适度规模经营前提条件;加强教育培训力度,提高农户职业素养,培养适度规模经营职业队伍;扩大融资渠道,改善粮食补贴模式,克服适度规模经营资金瓶颈;充分考虑地区差异,区分不同的地域类型,分区分类推进适度规模经营。     

农村减贫效率及其空间差异研究——基于DEA-ESDA模型的分析

[目的]通过对2011~2015年间全国以及各区域层面的农村减贫效率进行测度,探讨其空间差异及变化特征。[方法]文章采用投入导向的DEA-BCC模型测算农村减贫效率值,并借助探索性数据分析法(ESDA)对农村减贫效率的空间差异和变化展开分析。[结果](1)我国农村减贫综合技术效率相对较低,未能充分挖掘现有资源投入的潜力,纯技术效率整体偏小是造成综合技术效率较低的重要原因;(2)省际农村减贫效率在2011~2015年整体呈现出先减后增的趋势,并表现出西高东低的阶梯形空间布局;(3)农村减贫的综合技术效率存在正自相关性,高高聚集的区域主要集中在西部地区,低低聚集区域呈现由东北向京津都市区移转的趋势;(4)减贫综合技术效率的热点区域主要集中在西北与西南两大区域,且具有较强的稳定性;冷点区域主要分布在江西、安徽及东部沿海地区,较为稳定的冷点区域主要集中在东北及环渤海地区。[结论]我国农村减贫效率存在显著的空间异质性的特征,需要精准地识别出局部性致贫因素,因地制宜地制定出具有区域联动特点的空间扶贫开发策略。     

Bitcoin price and its marginal cost of production: support for a fundamental value

This study back-tests a marginal cost of production model proposed to value the digital currency Bitcoin. Results from both conventional regression and vector autoregression (VAR) models show that the marginal cost of production plays an important role in explaining Bitcoin prices, challenging recent allegations that Bitcoins are essentially worthless. Even with markets pricing Bitcoin in the thousands of dollars each, the valuation model seems robust. The data show that a price bubble that began in the Fall of 2017 resolved itself in early 2018, converging with the marginal cost model. This suggests that while bubbles may appear in the Bitcoin market, prices will tend to this bound and not collapse to zero.     

Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis

Background: Biologic treatments have enhanced the treatment outcomes of patients with active ankylosing spondylitis (AS). Until recently, TNF-alpha-inhibitors have been the only biologics approved for the treatment of active AS. The objective of this study was to assess the potential financial impact of the first non-TNF-alpha biologic secukinumab (fully human IL-17A-inhibitor) vs adalimumab (TNF-alpha-inhibitor) in the treatment of AS in Finland.

Materials and methods: In this model-based budget impact analysis, patients were treated either with secukinumab (150?mg) or adalimumab (40?mg). The number of patients and market share of different biologics were based on national reimbursement registry data. Adalimumab was the most commonly used biologic treatment for AS, and in the base case analysis all adalimumab patients are assumed to switch to secukinumab. Response rates were based on a matching-adjusted indirect comparison between secukinumab and adalimumab. Patients not achieving response were switched to another biologic treatment.

Results: Treating AS patients with secukinumab instead of adalimumab leads to potential savings of 18.2 million euros within a 5-year time period. The total costs within the follow-up time were 59.5 million euros and 77.7 million euros with and without secukinumab, respectively. According to sensitivity analyses, a higher adoption rate of secukinumab corresponds to higher potential savings.

Conclusions: Secukinumab is a cost-saving treatment option compared with adalimumab in the treatment of AS in Finland. More patients could be treated with a biologic by allocating resources more efficiently.     

Decrease in American birth rates makes it imperative for the United States to implement state mandated fertility coverage

In recent years, the prevalence of infertility has increased due to delayed childbearing and an increase in the rate of male infertility. Given the high cost of fertility treatment, this option is not valid for families with a low income, and those who can afford it usually choose to have multiple embryo transfer, which has led to an increase in multiple birth rates and an increase in the cost of perinatal care. Due to the expected increase in infertility and decrease in the national live birth rate, the US should set a plan to fund infertility treatment and lead a policy for single embryo transfer. This will offset the decrease in the national birth rates and decrease expenditure on perinatal and neonatal complications resulting from multiple births.